Abstract
Mu-opioid receptor (MOR) belongs to the G-protein coupled receptors, which couples specifically to Gi/Go heterotrimeric G proteins. Our recent studies suggest that Gi2 not only is responsible for opioid agonist inhibition of adenylyl cyclase activity, but also performs as a scaffold to recruit the receptor and post-receptor signaling molecules to form a signaling complex for adenylyl cyclase superactivation after chronic agonist treatment. Our current results show that in neuroblastoma Neuro2A-MOR (N2AMOR) cells, MOR and Gi2 are both located in lipid rafts fractions, the plasma membrane microdomains that are rich in sphingolipid and cholesterol. Using co-immunoprecipitation and confocal fluorescent microscopy techniques, MOR and Gi2 are colocalized and interacted with each other in lipid rafts. Disruption of lipid rafts by methyl-beta-cyclodextrin causes the loss of colocalization of mu-receptors and Gi2. More importantly, disruption of lipid rafts also causes the loss of MOR activities, including the inhibition of agonist-induced intracellular cAMP level and mobilization of the intracellular Ca2+. Furthermore these activities can be restored after adding back cholesterol. Taken together, these observations suggest that G-protein scaffolding and lipid raft localization are essential for the receptor to regulate the signal transduction precisely and efficiently. (Research supported by NIDA grants DA0166774 and DA007339)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.